Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

FDA Releases List of Evidence-Based PGx Variants

The agency compiled the evolving list by drawing on information from drug labeling and the published literature and is asking stakeholders to provide feedback.

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Genentech will use Adaptive's ClonoSeq assay for MRD testing in a CLL study. Adaptive will receive upfront and sample testing payments of undisclosed amounts.

PGDx Gets IDE For Tissue NGS Test in Merck Immunotherapy Trial

The company is using the test to direct patient enrollment and treatment stratification in a trial of pembrolizumab (Keytruda) combination treatments.

HalioDx, OSE Immunotherapeutics Collaborate on Immune Biomarkers for NSCLC Treatment

HalioDx will perform immune biomarker exploratory work for the collaboration, which will focus on defining the profile of responder patients to Tedopi.

HalioDx, Kite Pharma Extend Biomarker Collaboration

The extended deal covers multiple blood cancer and solid tumor indications and will leverage several HalioDx technologies and approaches.

Nov 18, 2019

Centogene to Provide Diagnostic Testing Services for PTC Therapeutics Gene Therapy Program

Nov 13, 2019

Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences

Nov 07, 2019

Centogene Prices US IPO at $14 per Share

Oct 17, 2019

Centogene Files to Go Public in US

Oct 10, 2019

FDA Issues Final Guidance on IVD Reviews for Investigational Cancer Drug Trials

Oct 10, 2019

UTC Labs, Principals Agree to Pay $42.6M in PGx Testing Fraud Case

Aug 16, 2019

Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

Aug 13, 2019

Adaptive Biotechnologies Q2 Revenues Rise 91 Percent

Jul 24, 2019

Gray Foundation Awards $25M in Cancer Research Grants

Jun 24, 2019

SpeeDx, GSK Sign Test Supply, Development Deal

May 07, 2019

Adial Pharmaceuticals, Eurofins Scientific Partner on CDx for Alcohol Use Disorder Drug

Apr 24, 2019

Macrogen, Exosome Plus Ink MOU, Deal for Exosome Isolation Kits

Feb 27, 2019

Danaher Prices $2.76B Offering of Common, Preferred Stock

Sep 26, 2018

Konica Minolta Launches Precision Medicine Business

Mar 14, 2018

Exosome Diagnostics, Intezyne to Develop Exosomal RNA Assay for Novel CRP Inhibitor

Feb 09, 2018

Q-State Subsidiary Buys Claritas Assets, Plans Relaunch of Lab to Support Drug Discovery Programs

Premium

Dec 06, 2017

Janssen to Evaluate Genomic Health GPS Test for Use in Prostate Cancer Drug Pipeline

Aug 10, 2017

Alexion, Sema4 Partner to Improve Diagnosis of Rare Diseases

Dec 08, 2016

AbbVie Pursues Phase III Veliparib Study in BRCA Mutated Breast Cancer After Phase II Survival Trend